These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7545499)

  • 41. Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report.
    Convit J; Ulrich M; Polegre MA; Avila A; Rodríguez N; Mazzedo MI; Blanco B
    Mem Inst Oswaldo Cruz; 2004 Feb; 99(1):57-62. PubMed ID: 15057348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological correlates of cure in the first American cutaneous leishmaniasis patient treated by immunotherapy in Argentina. A case report.
    García Bustos MF; Barrio AB; Parodi Ramoneda CM; Ramos F; Mora MC; Convit J; Basombrío MA
    Invest Clin; 2011 Dec; 52(4):365-75. PubMed ID: 22523846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis.
    Skeiky YA; Benson DR; Costa JL; Badaro R; Reed SG
    Infect Immun; 1997 Dec; 65(12):5368-70. PubMed ID: 9393843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgE antibody against surface antigens of Leishmania promastigotes in American cutaneous leishmaniasis.
    Lynch NR; Malavé C; Turner KJ; Infante B
    Parasite Immunol; 1986 Mar; 8(2):109-16. PubMed ID: 3517764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutaneous leishmaniasis in Ethiopia: I. Lymphocyte transformation and antibody titre.
    Schurr E; Kidane K; Yemaneberhan T; Wunderlich F
    Trop Med Parasitol; 1986 Dec; 37(4):403-8. PubMed ID: 3563321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adhesion molecules in lesions of American cutaneous leishmaniasis.
    Tapia FJ; Cáceres-Dittmar G; Sánchez MA; Fernández CT; Rondón AJ; Convit J
    Exp Dermatol; 1994 Feb; 3(1):17-22. PubMed ID: 7914808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parasitic oligosaccharide residues recognized by patients with mucocutaneous and localized cutaneous leishmaniasis.
    Avila JL; Rojas M; Rodas A; Convit J
    Am J Trop Med Hyg; 1992 Sep; 47(3):284-90. PubMed ID: 1524141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis.
    Conceição-Silva F; Dórea RC; Pirmez C; Schubach A; Coutinho SG
    Clin Exp Immunol; 1990 Feb; 79(2):221-6. PubMed ID: 2311299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous leishmaniasis in the guinea pig. Delayed-type hypersensitivity, lymphocyte stimulation, and inhibition of macrophage migration.
    Blewett TM; Kadivar DM; Soulsby EJ
    Am J Trop Med Hyg; 1971 Jul; 20(4):546-51. PubMed ID: 5568123
    [No Abstract]   [Full Text] [Related]  

  • 50. [A comparison of the cellular immune response and some aspects of its regulation in patients with American cutaneous leishmaniasis and American trypanosomiasis].
    Castés M
    Acta Cient Venez; 1986; 37(4):363-72. PubMed ID: 3122480
    [No Abstract]   [Full Text] [Related]  

  • 51. Leishmania major: common antigen responsible for induction of delayed-type hypersensitivity response in guinea pigs.
    Khabiri AR; Bagheri F; Assmar M
    Parasitol Res; 2007 Feb; 100(3):629-32. PubMed ID: 17013648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis.
    Shaw JJ; Lainson R
    Trans R Soc Trop Med Hyg; 1975; 69(3):323-35. PubMed ID: 52214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical immunological variants of leishmaniasis].
    Shuĭkina EE
    Med Parazitol (Mosk); 1980; 49(3):75-81. PubMed ID: 6993910
    [No Abstract]   [Full Text] [Related]  

  • 54. Leishmaniasis: recognition and management with a focus on the immunocompromised patient.
    Choi CM; Lerner EA
    Am J Clin Dermatol; 2002; 3(2):91-105. PubMed ID: 11893221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis.
    Carvalho EM; Barral A; Costa JM; Bittencourt A; Marsden P
    Acta Trop; 1994 Apr; 56(4):315-25. PubMed ID: 8023755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The Montenegro test in the epidemiology of South American leishmaniasis].
    Restrepo Isaza M
    Bol Oficina Sanit Panam; 1980 Aug; 89(2):130-8. PubMed ID: 6160863
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaccine for prophylaxis and immunotherapy, Brazil.
    Genaro O; de Toledo VP; da Costa CA; Hermeto MV; Afonso LC; Mayrink W
    Clin Dermatol; 1996; 14(5):503-12. PubMed ID: 8889328
    [No Abstract]   [Full Text] [Related]  

  • 58. The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis.
    Pinheiro RO; Pinto EF; Benedito AB; Lopes UG; Rossi-Bergmann B
    An Acad Bras Cienc; 2004 Sep; 76(3):519-27. PubMed ID: 15334250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muco-cutaneous leishmaniasis: intradermal test with a promastigote suspension and a crude extract from Leishmania braziliensis.
    Pellegrino J; Pereira LH; Furtado TA
    Rev Inst Med Trop Sao Paulo; 1977; 19(6):393-6. PubMed ID: 613434
    [No Abstract]   [Full Text] [Related]  

  • 60. Serological patterns and specificity in American cutaneous leishmaniasis.
    Ulrich M; Centeno M; Mattout Z; Convit J
    Am J Trop Med Hyg; 1988 Aug; 39(2):179-84. PubMed ID: 3044157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.